RMD:NYSE
Resmed Inc
$239.69
arrow_upward
+0.30%(+0.72) 1D
Oct 19, 2:30:23 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RMD...
Open
$235.50
High
$240.32
Low
$235.50
Mkt. cap
33.70B
Avg. vol.
1.20M
Volume
283.44K
Dividend
1.10%
Quarterly dividend
$0.66
Ex-dividend date
Aug 20, 2026
P/E ratio
22.98
52-wk high
$277.67
52-wk low
$180.26
EPS
$10.43
Beta
0.75
Shares outstanding
140.64M
No. of employees
11K
Open
$235.50
High
$240.32
Low
$235.50
Mkt. cap
33.70B
Avg. vol.
1.20M
Volume
283.44K
Dividend
1.10%
Quarterly dividend
$0.66
Ex-dividend date
Aug 20, 2026
P/E ratio
22.98
52-wk high
$277.67
52-wk low
$180.26
EPS
$10.43
Beta
0.75
Shares outstanding
140.64M
No. of employees
11K
News stories
From web sources and news partners
Stock Titan
·
6 hours ago
A fabric sleep apnea mask is designed to fit 96% of people. Resmed says it will be available in the U.S. Oct. 28.
Investing.com Nigeria
·
14 hours ago
Form 4 ResMed Inc: Aaron Bloomer (CFO) For: 14 August By Investing.com
Profile
Resmed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers.
Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024. Wikipedia
About Resmed Inc
CEOMichael J. Farrell
Employees11.4K
FoundedJun 1989
HeadquartersSan Diego, California, United States
SectorMedical device
Websiteresmed.com
Analyst ratings
Based on 13 analysts giving stock ratings to RMD in the past 3 months
Buy
Buy
5
Hold
8
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for RMD in the last 3 months.
Highest
Current $239.69
$320.00 (+33.51%)
Average
$244.70 (+2.09%)
Lowest
$213.00 (-11.14%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Anthony Petrone Mizuho Securities | Buy | Reiterated | $240.00 | +0.1% | 10/13/2026 |
Lyanne Harrison Bank of America Securities | Buy | Reiterated | $320.00 | +33.5% | 10/13/2026 |
Jonathan Block Stifel Nicolaus | Hold | Maintained | $235.00 | -2% | 10/02/2026 |
Craig Wong-Pan RBC Capital | Buy | Upgraded | $262.00 | +9.3% | 09/15/2026 |
Laura Sutcliffe Citi | Hold | Maintained | $240.00 | +0.1% | 09/10/2026 |
Brett Fishbin KeyBanc | Buy | Reiterated | $267.00 | +11.4% | 08/31/2026 |
Jackson Philips Rothschild & Co Redburn | Hold | Initiated | $230.00 | -4% | 08/19/2026 |
Unknown Analyst Oppenheimer | Hold | Reiterated | - | - | 08/07/2026 |
Adam Maeder Piper Sandler | Hold | Maintained | $225.00 | -6.1% | 08/07/2026 |
David Rescott Robert W. Baird | Hold | Maintained | $213.00 | -11.1% | 08/07/2026 |
Nathan Treybeck Wells Fargo | Hold | Reiterated | $215.00 | -10.3% | 08/07/2026 |
Brandon Vazquez William Blair | Buy | Maintained | - | - | 08/07/2026 |
Michael Matson Needham | Hold | Maintained | - | - | 08/07/2026 |
David Bailey Morgan Stanley | Hold | Maintained | $230.00 | -4% | 07/13/2026 |
Matthew Taylor Jefferies | Hold | Maintained | $225.00 | -6.1% | 07/10/2026 |
Unknown Analyst Jefferies | Hold | Reiterated | $225.00 | -6.1% | 07/10/2026 |
Unknown Analyst Wells Fargo | Hold | Maintained | $227.00 | -5.3% | 05/01/2026 |
Unknown Analyst J.P. Morgan | Buy | Maintained | - | - | 04/15/2026 |
Chris Cooper J.P. Morgan | Buy | Initiated | - | - | 04/15/2026 |
Unknown Analyst Evercore ISI | Buy | Maintained | $255.00 | +6.4% | 04/13/2026 |
Larry Biegelsen Wells Fargo | Hold | Maintained | $270.00 | +12.6% | 01/30/2026 |
Mark Wilson CFA RBC Capital | Buy | Maintained | $314.00 | +31% | 01/30/2026 |
Next call in 10 days
Thu, Oct 29, 10:30 PM
Fiscal period
Q1 2027
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $2.67
Revenue / Est. (USD)
- / 1.39B
Fiscal Q1 2027 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 1.34B | 1.42B | 1.43B | 1.46B |
Cost of goods sold | 506.94M | 536.28M | 532.58M | 594.13M |
Cost of revenue | 506.94M | 536.28M | 532.58M | 594.13M |
Research and development expenses | 87.32M | 90.97M | 94.27M | 105.72M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 259.19M | 275.70M | 279.80M | 293.36M |
Operating expense | 366.29M | 386.24M | 393.16M | 417.88M |
Total operating expenses | 873.24M | 922.51M | 925.74M | 1.01B |
Operating income | 462.35M | 500.30M | 505.67M | 451.64M |
Other non operating income | -3.84M | 42.00K | 181.00K | 4.40M |
EBT including unusual items | 446.79M | 496.15M | 502.31M | 474.16M |
EBT excluding unusual items | 468.79M | 504.48M | 518.30M | 476.09M |
Income tax expense | 98.26M | 103.56M | 103.58M | 90.73M |
Effective tax rate | 21.99% | 20.87% | 20.62% | 19.14% |
Other operating expenses | - | - | - | - |
Net income | 348.54M | 392.59M | 398.73M | 383.43M |
Net profit margin | 26.10% | 27.59% | 27.86% | 26.20% |
Earnings per share | 2.55 | 2.81 | 0.29 | 0.30 |
Interest and investment income | 4.69M | 4.46M | 3.80M | 31.76M |
Interest expense | - | - | - | - |
Net interest expenses | 4.69M | 4.46M | 3.80M | 31.76M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 503.64M | 543.79M | 558.22M | 490.13M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1